Annual Non Current Assets
$6.52 M
-$1.49 M-18.64%
December 31, 2023
Summary
- As of February 8, 2025, KPTI annual long term assets is $6.52 million, with the most recent change of -$1.49 million (-18.64%) on December 31, 2023.
- During the last 3 years, KPTI annual non current assets has fallen by -$30.00 million (-82.15%).
- KPTI annual non current assets is now -86.63% below its all-time high of $48.75 million, reached on December 31, 2016.
Performance
KPTI Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$4.72 M
-$716.00 K-13.17%
September 30, 2024
Summary
- As of February 8, 2025, KPTI quarterly long term assets is $4.72 million, with the most recent change of -$716.00 thousand (-13.17%) on September 30, 2024.
- Over the past year, KPTI quarterly non current assets has dropped by -$716.00 thousand (-13.17%).
- KPTI quarterly non current assets is now -92.41% below its all-time high of $62.17 million, reached on June 30, 2020.
Performance
KPTI Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
KPTI Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.6% | -13.2% |
| 3 y3 years | -82.2% | -62.3% |
| 5 y5 years | -1.0% | -72.0% |
KPTI Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -78.1% | at low | -84.1% | at low |
| 5 y | 5-year | -82.2% | at low | -92.4% | at low |
| alltime | all time | -86.6% | +2313.7% | -92.4% | +1648.5% |
Karyopharm Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.72 M(-13.2%) |
| Jun 2024 | - | $5.44 M(-10.8%) |
| Mar 2024 | - | $6.09 M(-6.5%) |
| Dec 2023 | $233.92 M(-33.2%) | $6.52 M(-3.3%) |
| Sep 2023 | - | $6.74 M(+4.5%) |
| Jun 2023 | - | $6.45 M(-11.2%) |
| Mar 2023 | - | $7.26 M(-9.4%) |
| Dec 2022 | $350.16 M(+27.1%) | $8.01 M(-6.4%) |
| Sep 2022 | - | $8.56 M(-39.0%) |
| Jun 2022 | - | $14.03 M(-19.8%) |
| Mar 2022 | - | $17.50 M(-41.1%) |
| Dec 2021 | $275.61 M(-0.3%) | $29.70 M(+137.3%) |
| Sep 2021 | - | $12.52 M(-4.2%) |
| Jun 2021 | - | $13.06 M(-32.6%) |
| Mar 2021 | - | $19.40 M(-46.9%) |
| Dec 2020 | $276.53 M(-0.7%) | $36.52 M(-30.0%) |
| Sep 2020 | - | $52.14 M(-16.1%) |
| Jun 2020 | - | $62.17 M(+37.5%) |
| Mar 2020 | - | $45.22 M(+175.9%) |
| Dec 2019 | $278.57 M(-16.7%) | $16.39 M(-2.9%) |
| Sep 2019 | - | $16.88 M(+10.5%) |
| Jun 2019 | - | $15.27 M(-3.2%) |
| Mar 2019 | - | $15.78 M(+139.8%) |
| Dec 2018 | $334.61 M | $6.58 M(-21.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $8.43 M(-29.9%) |
| Jun 2018 | - | $12.03 M(-7.9%) |
| Mar 2018 | - | $13.06 M(-59.0%) |
| Dec 2017 | $148.42 M(+12.8%) | $31.87 M(-24.3%) |
| Sep 2017 | - | $42.09 M(+5.2%) |
| Jun 2017 | - | $40.03 M(-7.4%) |
| Mar 2017 | - | $43.20 M(-11.4%) |
| Dec 2016 | $131.64 M(-25.9%) | $48.75 M(-8.7%) |
| Sep 2016 | - | $53.37 M(+14.3%) |
| Jun 2016 | - | $46.70 M(-13.5%) |
| Mar 2016 | - | $53.99 M(+42.7%) |
| Dec 2015 | $177.60 M(-14.5%) | $37.84 M(-2.0%) |
| Sep 2015 | - | $38.63 M(+1.5%) |
| Jun 2015 | - | $38.04 M(-11.0%) |
| Mar 2015 | - | $42.72 M(+239.4%) |
| Dec 2014 | $207.75 M(+31.5%) | $12.59 M(+230.4%) |
| Sep 2014 | - | $3.81 M(+59.0%) |
| Jun 2014 | - | $2.40 M(+39.4%) |
| Mar 2014 | - | $1.72 M(+536.7%) |
| Dec 2013 | $157.96 M(>+9900.0%) | $270.00 K(-88.4%) |
| Sep 2013 | - | $2.32 M(+704.9%) |
| Jun 2013 | - | $288.00 K(-19.3%) |
| Dec 2012 | $954.00 K(-86.1%) | $357.00 K |
| Dec 2011 | $6.87 M | - |
FAQ
- What is Karyopharm Therapeutics annual long term assets?
- What is the all time high annual non current assets for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual non current assets year-on-year change?
- What is Karyopharm Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly non current assets year-on-year change?
What is Karyopharm Therapeutics annual long term assets?
The current annual non current assets of KPTI is $6.52 M
What is the all time high annual non current assets for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual long term assets is $48.75 M
What is Karyopharm Therapeutics annual non current assets year-on-year change?
Over the past year, KPTI annual long term assets has changed by -$1.49 M (-18.64%)
What is Karyopharm Therapeutics quarterly long term assets?
The current quarterly non current assets of KPTI is $4.72 M
What is the all time high quarterly non current assets for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly long term assets is $62.17 M
What is Karyopharm Therapeutics quarterly non current assets year-on-year change?
Over the past year, KPTI quarterly long term assets has changed by -$716.00 K (-13.17%)